<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00716183</url>
  </required_header>
  <id_info>
    <org_study_id>Promast08</org_study_id>
    <nct_id>NCT00716183</nct_id>
  </id_info>
  <brief_title>Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis</brief_title>
  <official_title>Phase 2/3 Evaluation of Three Lactobacilli Strains Isolated From Human Milk for the Treatment of Infectious Mastitis During the Lactation Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Complutense de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Complutense de Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A total of 300 women with lactational infectious mastitis will daily ingest 9 log10 cfu of
      Lactobacillus salivarius HN6, Lactobacillus reuteri CR20 or Lactobacillus fermentum LC40 for
      4 weeks. The three lactobacilli strains were originally isolated from milk of healthy women.
      On days 0 and 28, milk samples will be collected, and staphylococci/streptococci and
      lactobacilli will be counted and identified. Evolution of clinical signs will be recorded by
      midwifes on days 0, 7, 14 and 28.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Staphylococcal and/or streptococcal count in milk</measure>
    <time_frame>0 and 28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of local and systemic symptoms associated to mastitis</measure>
    <time_frame>days 0, 7, 14 and 28</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Mastitis</condition>
  <arm_group>
    <arm_group_label>Probiotic 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women receiving Lactobacillus salivarius HN6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women receiving Lactobacillus reuteri CR20</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women receiving Lactobacillus fermentum LC40</description>
  </arm_group>
  <arm_group>
    <arm_group_label>beta-lactam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The evolution of the women ascribed to the other three arms will be compared with that of 100 women suffering lactational mastitis that will follow a conventional antibiotic treatment as prescribed by the pediatrician/gynecologist</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lactobacillus salivarius HN6</intervention_name>
    <description>9 log colony-forming units, capsules, daily, four weeks</description>
    <arm_group_label>Probiotic 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lactobacillus reuteri CR20</intervention_name>
    <description>9 log colony-forming units, capsules, daily, four weeks</description>
    <arm_group_label>Probiotic 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lactobacillus fermentum LC40</intervention_name>
    <description>9 log colony-forming units, capsules, daily, four weeks</description>
    <arm_group_label>Probiotic 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Beta-lactam antibiotic</intervention_name>
    <description>Use of amoxicillin, cloxacillin or amoxicillin/clavulanic acid(500-750 mg), orally, every 8-12 h, for 2-3 weeks (as prescribed by the physician responsible for the clinical diagnosis of lactational mastitis)</description>
    <arm_group_label>beta-lactam</arm_group_label>
    <other_name>Amoxicillin (generic), Cloxacillin (generic), Amoxicillin/clavulanic acid (generic), Clamoxyl, Orbenin, Augmentine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of mastitis

          -  Staphylococcal and/or streptococcal count higher than 3000 colony-forming units per ml
             of milk

          -  Milk leukocyte count higher 6 log10/mL

          -  Must be able to provide a milk sample without the aid of a milk pump

        Exclusion Criteria:

          -  Mammary abscesses

          -  Any kind of parallel disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dpt. Nutricion, Bromatologia y Tecnologia de los Alimentos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Jiménez E, Fernández L, Maldonado A, Martín R, Olivares M, Xaus J, Rodríguez JM. Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl Environ Microbiol. 2008 Aug;74(15):4650-5. doi: 10.1128/AEM.02599-07. Epub 2008 Jun 6.</citation>
    <PMID>18539795</PMID>
  </reference>
  <reference>
    <citation>Martín R, Olivares M, Marín ML, Fernández L, Xaus J, Rodríguez JM. Probiotic potential of 3 Lactobacilli strains isolated from breast milk. J Hum Lact. 2005 Feb;21(1):8-17; quiz 18-21, 41.</citation>
    <PMID>15681631</PMID>
  </reference>
  <reference>
    <citation>Martín R, Langa S, Reviriego C, Jimínez E, Marín ML, Xaus J, Fernández L, Rodríguez JM. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003 Dec;143(6):754-8.</citation>
    <PMID>14657823</PMID>
  </reference>
  <reference>
    <citation>Martín R, Heilig GH, Zoetendal EG, Smidt H, Rodríguez JM. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol. 2007 Dec;103(6):2638-44.</citation>
    <PMID>18045446</PMID>
  </reference>
  <reference>
    <citation>Delgado S, Arroyo R, Martín R, Rodríguez JM. PCR-DGGE assessment of the bacterial diversity of breast milk in women with lactational infectious mastitis. BMC Infect Dis. 2008 Apr 18;8:51. doi: 10.1186/1471-2334-8-51.</citation>
    <PMID>18423017</PMID>
  </reference>
  <reference>
    <citation>Martín R, Jiménez E, Olivares M, Marín ML, Fernández L, Xaus J, Rodríguez JM. Lactobacillus salivarius CECT 5713, a potential probiotic strain isolated from infant feces and breast milk of a mother-child pair. Int J Food Microbiol. 2006 Oct 15;112(1):35-43. Epub 2006 Jul 14.</citation>
    <PMID>16843562</PMID>
  </reference>
  <reference>
    <citation>Olivares M, Díaz-Ropero MP, Martín R, Rodríguez JM, Xaus J. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbiol. 2006 Jul;101(1):72-9.</citation>
    <PMID>16834593</PMID>
  </reference>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2008</study_first_submitted>
  <study_first_submitted_qc>July 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2008</study_first_posted>
  <last_update_submitted>May 22, 2009</last_update_submitted>
  <last_update_submitted_qc>May 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Juan M. Rodríguez</name_title>
    <organization>Universidad Complutense de Madrid</organization>
  </responsible_party>
  <keyword>mastitis</keyword>
  <keyword>Staphylococcus</keyword>
  <keyword>Streptococcus</keyword>
  <keyword>lactation</keyword>
  <keyword>breastfeeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mastitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Lactams</mesh_term>
    <mesh_term>beta-Lactams</mesh_term>
    <mesh_term>Cloxacillin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

